The BIOSKIN programme


Herlev and Gentofte Hospital and the LEO Foundation Skin Immunology Research Center at the University of Copenhagen have established the BIOSKIN research programme with skin tissue and blood samples from 3,000 patients who suffer from psoriasis and eczema.

As a patient or researcher, you can take part in the programme and contribute to new knowledge that is critical in order to develop new and tailored treatments.

For patients

The patient recruitment for the programme begins in 2021. If you are a patient suffering from eczema or psoriasis, you will be able to make your contribution to science by taking part in the collection of data and samples for the new biobank.


We will continuously open calls for patient recruitment during the 2021-2025 programme period. In every call, we will look for certain patient groups or disease patterns. We may for instance enroll patients within a certain age group, with specific symptoms or a particular disease course. These different calls ensure that we will be able to investigate compelling research questions and collect all necessary data for the biobank.

The recruitment calls will be announced on this website and via patient organisations and Danish dermatology clinics.

If you would like to be included in one of the recruitment calls, please send an e-mail to


As a patient, you will be affiliated to the research unit at the Department of Dermatology and Allergy, Gentofte Hospital. Here, health professionals will follow up on you on a regular basis for a period of time, take skin and blood samples and collect other relevant information about you and the course of your disease. The visits will be planned according to the specific recruitment call you are enrolled in.


The purpose of the programme is to generate new knowledge about the prevention and treatment of skin diseases for researchers and dermatologists across the world. Research results will therefore be published in acknowledged scientific journals. It is always important to keep in mind that conducting research takes time.

You will also be able to stay informed about new results on this website.



For researchers

Close collaboration between clinical and basic researchers across hospital and university is at the core of the research programme. Along with close contact to patients through patient organisations, this interdisciplinary collaboration will ensure significant impact for patients.

The programme provides a unique opportunity to collect data and skin and blood samples from the same patients over the course of several years, creating new possibilities in science, which can ultimately lead to more effective treatments.


Results from the research programme will be published continuously in leading scientific journals and announced on this website.



Vacant positions will be announced on this website.



If you would like to learn more about the research programme, the biobank and how you can become involved, please contact Chairman of the Programme Board, Clinical Professor Lone Skov at


About the programme

For many years, researchers have had difficulties decoding why skin diseases such as psoriasis and eczema affect some people more than others, why some patient develop comorbidities and why some patients do not respond to treatment. The new BIOSKIN research programme - including a biobank - is about to change that by elucidating how skin diseases develop in patients over time.

The goal is to collect clinical data and skin and blood samples from 3,000 patients in order to gain new insights about some of the most common skin diseases such as psoriasis and eczema. Patients will be followed closely over time during the 2021-2025 program period.

The biobank is the first of its kind and aims to make new knowledge available to the research community across the world for the benefit of patients with skin diseases. The biobank will significantly affect how fast we are able to turn novel ideas into tangible results.


The research programme will be established by the LEO Foundation Skin Immunology Research Center at the University of Copenhagen and the Department of Dermatology and Allergy at Herlev and Gentofte Hospital. The programme is supported with DKK 40 million from the LEO Foundation and co-financed with DKK 20 million from Herlev and Gentofte Hospital and LEO Foundation Skin Immunology Research Center.